Inflammatory environment-responsive nanomicelles targeting CD44 alleviate allergic asthma by inhibiting the TLR4/MyD88-NFκB pathway
Fields of Study & Subjects
Inhalation and Respiratory Drug Delivery
Asthma and respiratory diseases
Nanoparticle-Based Drug Delivery
Publication details
- Journal / source
- Nano Today
- Publisher
- Elsevier BV
- Volume
- 67
- Pages
- 102973–102973
- Publication date
- 2 January 2026
- Language
- EN